DrugPatentWatch Database Preview

Taro Company Profile

Email this page to a colleague

TARO has two hundred and thirty approved drugs.

There are seven US patents protecting TARO drugs. There are four tentative approvals on TARO drugs.

There are thirty-two patent family members on TARO drugs in twelve countries and one hundred and twenty-one supplementary protection certificates in fourteen countries.

International Patents:	32
US Patents:	7
Tradenames:	120
Ingredients:	102
NDAs:	230
Patent Litigation for Taro:	See patent lawsuits for Taro
PTAB Cases with Taro as petitioner:	See PTAB cases with Taro as petitioner

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Taro	ETODOLAC	etodolac	TABLET, EXTENDED RELEASE;ORAL	076174-002	Mar 13, 2003	AB	RX	No	No		Start Trial				Start Trial
Taro Pharm Inds Ltd	TOPICORT	desoximetasone	OINTMENT;TOPICAL	018763-001	Sep 30, 1983		DISCN	Yes	No		Start Trial				Start Trial
Taro	IBUPROFEN	ibuprofen	SUSPENSION;ORAL	209204-001	Jun 23, 2017	AB	RX	No	No		Start Trial				Start Trial
Taro	LIDOCAINE	lidocaine	OINTMENT;TOPICAL	086724-001	Approved Prior to Jan 1, 1982	AT	RX	No	No		Start Trial				Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Taro	FLO-PRED	prednisolone acetate	SUSPENSION;ORAL	022067-001	Jan 17, 2008	5,881,926	Start Trial
Taro	FLO-PRED	prednisolone acetate	SUSPENSION;ORAL	022067-001	Jan 17, 2008	6,102,254	Start Trial
Taro	FLO-PRED	prednisolone acetate	SUSPENSION;ORAL	022067-001	Jan 17, 2008	6,656,482	Start Trial
Taro	FLO-PRED	prednisolone acetate	SUSPENSION;ORAL	022067-001	Jan 17, 2008	6,071,523	Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Topical Spray	0.25%	➤ Subscribe	2013-12-18
➤ Subscribe	Topical Lotion	0.5%	➤ Subscribe	2011-03-16

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
China	101287374	Start Trial
Australia	2006278620	Start Trial
European Patent Office	2523660	Start Trial
World Intellectual Property Organization (WIPO)	2007019184	Start Trial
>Country	>Patent Number	>Estimated Expiration

Subscribe to access the full database, or Start Trial
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
1304992	132013902214376	Italy	Start Trial	PRODUCT NAME: CLINDAMICINA FOSFATO E TRETINOINA(ACNATAC); AUTHORISATION NUMBER(S) AND DATE(S): PA1332/043/001, 20130322;042056010/M - 022/M, 20130718
1110543	08C0004	France	Start Trial	PRODUCT NAME: DESLORATADINE; PSEUDOEPHEDRINE SULFATE; REGISTRATION NO/DATE: EU/1/07/399/001 20070730
1499331	13C0055	France	Start Trial	PRODUCT NAME: SULFATE DE SODIUM ANHYDRE, SULFATE DE MAGNESIUM HEPTAHYDRATE, SULFATE DE POTASSIUM; NAT. REGISTRATION NO/DATE: NL41696 20130426; FIRST REGISTRATION: 434323 20130220
1499331	SPC/GB13/034	United Kingdom	Start Trial	PRODUCT NAME: IZINOVA CONCENTRATE FOR ORAL SOLUTION. THE ACTIVE SUBSTANCE IS A MIXTURE OF 3 SALTS:SODIUM SULPHATE ANHYDROUS, MAGNESIUM SULPHATE HEPTAHYDRATE AND POTASSIUM SULPHATE.; REGISTERED: BE BE434323 20130220; UK PL34926/0016 20130313
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.